# OnCo record actym-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/actym-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "actym-therapeutics" ;
  schema:name "Actym Therapeutics"@en ;
  schema:description "Actym Therapeutics uses a weakened, engineered strain of Salmonella bacteria, given into a vein, to carry immune-activating signals into tumours. Its first medicine, ACTM-838, reached an early trial in advanced solid tumours, which the registry now lists as terminated."@en ;
  schema:url <https://onco.cc/companies/actym-therapeutics/>, <https://www.actymthera.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.actymthera.com/>, <https://clinicaltrials.gov/study/NCT06336148>, <https://www.actymthera.com/news/actym-therapeutics-announces-ind-clearance-for-phase-1-clinical-trial-investigating-lead-program-actm-838-in-patients-with-solid-tumors> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/engineered-bacteria-therapy/> .